Live feed
Filing
SC 13G
SC 13G0001104659-20-026030·Fresh Tracks Therapeutics, Inc.
Schedule 13G ownership disclosure
Brickell Biotech, Inc.
Security class unavailable · CUSIP: 10802T105
Event date: 2020-02-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 965,723
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-026030
- Form type
- SC 13G
- Filer
- Fresh Tracks Therapeutics, Inc.
- CIK
- CIK 819050
- Filed
- Feb 27, 2020
- Reporting period
- Feb 20, 2020
- Description
- Schedule 13G beneficial ownership